IP Library Granted Patent US 7,718,617
Granted Patent B2
US 7,718,617 · App. 11/621,246 · Granted May 18, 2010

Methods for preserving organs and tissues

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,718,617
App. No.
11/621,246
Granted
May 18, 2010
Kind
B2
Abstract

The invention relates to a method for preserving an organ or tissue comprising contacting the organ or tissue with an effective amount of a kallikrein inhibitor and solutions useful for such a method. Also provided is a method for reducing reperfusion injury of an organ during surgery and/or following removal of the organ from a subject comprising placing the organ in an organ storage and preservative solution, wherein the solution comprises a kallikrein inhibitor.

Claims (10)

1. A method for preserving an organ or tissue, the method comprising contacting the organ or tissue with an effective amount of a physiologically acceptable ex vivo organ preservation solution containing a polypeptide that comprises amino acids 3-60 of SEQ ID NO:2,

wherein the polypeptide inhibits kallikrein.

2. The method according to claim 1 , wherein the polypeptide comprises SEQ ID NO:2.

3. The method of claim 1 , wherein the organ or tissue is selected from the group consisting of: heart, lung, kidney, pancreas, liver, intestine, endothelial tissue, vascular tissue and skin.

4. A method for preserving an organ or tissue during transplantation, the method comprising contacting the organ or tissue with an effective amount of a physiologically acceptable ex vivo organ preservation solution containing a polypeptide that comprises amino acids 3-60 of SEQ ID NO:2, wherein the polypeptide inhibits kallikrein.

5. The method according to claim 4 , wherein the polypeptide comprises SEQ ID NO:2.

6. The method of claim 4 , wherein the organ or tissue is selected from the group consisting of: heart, lung, kidney, pancreas, liver, intestine, endothelial tissue, vascular tissue and skin.

7. A method for preserving an organ or tissue during storage, the method comprising contacting the organ or tissue with an effective amount of a physiologically acceptable ex vivo organ preservation solution containing a polypeptide that comprises amino acids 3-60 of SEQ ID NO:2, wherein the polypeptide inhibits kallikrein.

8. The method according to claim 7 , wherein the polypeptide comprises SEQ ID NO:2.

9. The method of claim 7 , wherein the organ or tissue is selected from the group consisting of: heart, lung, kidney, pancreas, liver, intestine, endothelial tissue, vascular tissue and skin.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2021
From: DYAX CORP.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056268/0983 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2007
From: CICARDI, MARCO; BERGAMASCHINI, LUIGI
To: DYAX CORP.
Reel/Frame 018763/0199 →